Market Cap | ₹1,233Cr |
ROE | 7.41% |
P/E Ratio(TTM) | -135.35 |
EPS(TTM) | -0.99 |
P/B Ratio | 3.34 |
Dividend Yield | 0.37% |
Industry P/E | 33.84 |
Book Value | 40.16 |
Debt to Equity | 0.21 |
Face Value | 1 |
Parent Organisation | Themis Medicare |
Managing Director | Dr. Sachin Patel |
NSE Symbol | THEMISMED |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 99.55 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.60 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.24 | ||
Wockhardt | NA (0.00%) | -197.40 |